Goldman Sachs’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.8M | Buy |
475,000
+421,000
| +780% | +$33.7M | ﹤0.01% | 2070 |
|
|
2025
Q4 | $5.15M | Sell |
54,000
-370,000
| -87% | -$36.3M | ﹤0.01% | 3716 |
|
|
2025
Q3 | $41.4M | Buy |
424,000
+370,000
| +685% | +$38.3M | 0.01% | 1580 |
|
|
2025
Q2 | $5.8M | Hold |
54,000
| – | – | ﹤0.01% | 3278 |
|
|
2025
Q1 | $5.45M | Hold |
54,000
| – | – | ﹤0.01% | 3266 |
|
|
2024
Q4 | $4.82M | Hold |
54,000
| – | – | ﹤0.01% | 3495 |
|
|
2024
Q3 | $4.53M | Buy |
+54,000
| New | +$4.26M | ﹤0.01% | 3432 |
|
|
2024
Q2 | – | Sell |
-140,000
| Closed | -$9.59M | – | 5666 |
|
|
2024
Q1 | $9.59M | Sell |
140,000
-12,900
| -8% | -$829K | ﹤0.01% | 2487 |
|
|
2023
Q4 | $8.84M | Sell |
152,900
-77,100
| -34% | -$4.12M | ﹤0.01% | 2648 |
|
|
2023
Q3 | $12.1M | Buy |
230,000
+67,600
| +42% | +$3.55M | ﹤0.01% | 2223 |
|
|
2023
Q2 | $8.78M | Buy |
+162,400
| New | +$8.48M | ﹤0.01% | 2576 |
|
|
2022
Q4 | – | Sell |
-21,600
| Closed | -$837K | – | 5992 |
|
|
2022
Q3 | $837K | Sell |
21,600
-8,600
| -28% | -$345K | ﹤0.01% | 4631 |
|
|
2022
Q2 | $1.13M | Sell |
30,200
-13,200
| -30% | -$537K | ﹤0.01% | 4521 |
|
|
2022
Q1 | $1.92M | Sell |
43,400
-59,300
| -58% | -$2.57M | ﹤0.01% | 4298 |
|
|
2021
Q4 | $4.36M | Buy |
102,700
+42,700
| +71% | +$1.79M | ﹤0.01% | 3545 |
|
|
2021
Q3 | $2.6M | Hold |
60,000
| – | – | ﹤0.01% | 3946 |
|
|
2021
Q2 | $2.57M | Buy |
60,000
+34,700
| +137% | +$1.46M | ﹤0.01% | 3972 |
|
|
2021
Q1 | $978K | Sell |
25,300
-99,300
| -80% | -$3.76M | ﹤0.01% | 4632 |
|
|
2020
Q4 | $4.48M | Hold |
124,600
| – | – | ﹤0.01% | 3085 |
|
|
2020
Q3 | $4.76M | Sell |
124,600
-76,800
| -38% | -$2.96M | ﹤0.01% | 2945 |
|
|
2020
Q2 | $7.07M | Buy |
201,400
+168,300
| +508% | +$6.06M | ﹤0.01% | 2526 |
|
|
2020
Q1 | $1.08M | Buy |
33,100
+6,200
| +23% | +$242K | ﹤0.01% | 3696 |
|
|
2019
Q4 | $1.22M | Sell |
26,900
-38,200
| -59% | -$1.6M | ﹤0.01% | 3999 |
|
|
2019
Q3 | $2.65M | Buy |
65,100
+4,800
| +8% | +$203K | ﹤0.01% | 3342 |
|
|
2019
Q2 | $2.59M | Sell |
60,300
-46,400
| -43% | -$1.78M | ﹤0.01% | 3364 |
|
|
2019
Q1 | $4.09M | Sell |
106,700
-40,300
| -27% | -$1.54M | ﹤0.01% | 3141 |
|
|
2018
Q4 | $5.2M | Buy |
147,000
+145,400
| +9,088% | +$5.27M | ﹤0.01% | 2845 |
|
|
2018
Q3 | $62K | Hold |
1,600
| – | – | ﹤0.01% | 5250 |
|
|
2018
Q2 | $52K | Hold |
1,600
| – | – | ﹤0.01% | 5347 |
|
|
2018
Q1 | $44K | Sell |
1,600
-22,800
| -93% | -$620K | ﹤0.01% | 5502 |
|
|
2017
Q4 | $605K | Buy |
24,400
+3,200
| +15% | +$88.3K | ﹤0.01% | 4680 |
|
|
2017
Q3 | $618K | Buy |
21,200
+2,700
| +15% | +$74.6K | ﹤0.01% | 4948 |
|
|
2017
Q2 | $513K | Sell |
18,500
-6,000
| -24% | -$159K | ﹤0.01% | 5072 |
|
|
2017
Q1 | $609K | Sell |
24,500
-200,100
| -89% | -$4.87M | ﹤0.01% | 4833 |
|
|
2016
Q4 | $4.86M | Buy |
224,600
+100,100
| +80% | +$2.18M | ﹤0.01% | 3078 |
|
|
2016
Q3 | $2.96M | Buy |
124,500
+300
| +0.2% | +$7.16K | ﹤0.01% | 3488 |
|
|
2016
Q2 | $2.9M | Buy |
124,200
+48,400
| +64% | +$1.05M | ﹤0.01% | 3299 |
|
|
2016
Q1 | $1.43M | Sell |
75,800
-12,200
| -14% | -$214K | ﹤0.01% | 3775 |
|
|
2015
Q4 | $1.62M | Sell |
88,000
-135,800
| -61% | -$2.43M | ﹤0.01% | 3820 |
|
|
2015
Q3 | $3.67M | Sell |
223,800
-142,000
| -39% | -$2.43M | ﹤0.01% | 3172 |
|
|
2015
Q2 | $6.47M | Buy |
365,800
+133,000
| +57% | +$2.38M | ﹤0.01% | 2716 |
|
|
2015
Q1 | $4.13M | Sell |
232,800
-372,600
| -62% | -$5.89M | ﹤0.01% | 3086 |
|
|
2014
Q4 | $8.02M | Buy |
605,400
+168,500
| +39% | +$2.15M | ﹤0.01% | 2532 |
|
|
2014
Q3 | $5.16M | Sell |
436,900
-102,900
| -19% | -$1.3M | ﹤0.01% | 2981 |
|
|
2014
Q2 | $6.89M | Sell |
539,800
-1,616,900
| -75% | -$21M | ﹤0.01% | 2705 |
|
|
2014
Q1 | $29.2M | Sell |
2,156,700
-4,865,400
| -69% | -$63.9M | 0.01% | 1463 |
|
|
2013
Q4 | $84.4M | Buy |
7,022,100
+5,101,300
| +266% | +$60.3M | 0.03% | 710 |
|
|
2013
Q3 | $22.6M | Buy |
1,920,800
+282,100
| +17% | +$3.05M | 0.01% | 1529 |
|
|
2013
Q2 | $15.2M | Buy |
+1,638,700
| New | +$13.9M | 0.01% | 1730 |
|
Other funds holding BSX
VCM
VPM
Goldman Sachs's BSX Position: Q1 2026 in Review
Goldman Sachs increased its Boston Scientific (BSX) stake by 14% in Q1 2026, buying an estimated $185M and bringing the position to 18,891,624 shares worth $1.19B. The position accounts for 0.14% of the portfolio, ranked #133.
Goldman Sachs first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.58B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Goldman Sachs held 18,891,624 shares of Boston Scientific worth $1.19B as of Q1 2026.
- Goldman Sachs bought 2,312,707 Boston Scientific shares in Q1 2026, an estimated $185M.
- Boston Scientific made up 0.14% of Goldman Sachs's portfolio in Q1 2026, its #133 holding.
- Goldman Sachs first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Boston Scientific position peaked at $1.58B in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.